This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Endologix stock

Own Endologix stock in just a few minutes.

Posted

Fact checked

Endologix, Inc is a medical instruments & supplies business based in the US. Endologix shares (ELGX) are listed on the NASDAQ and all prices are listed in US Dollars. Endologix employs 488 staff and has a trailing 12-month revenue of around USD$136.3 million.

How to buy shares in Endologix

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Endologix. Find the stock by name or ticker symbol: ELGX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Endologix reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Endologix, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Endologix. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Endologix share price

Use our graph to track the performance of ELGX stocks over time.

Endologix shares at a glance

Information last updated 2020-10-20.
52-week range USD$0.0199 - USD$3.8
50-day moving average USD$0.0424
200-day moving average USD$0.4927
Wall St. target price USD$0.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-7.27

Buy Endologix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Endologix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Endologix financials

Revenue TTM USD$136.3 million
Gross profit TTM USD$91.1 million
Return on assets TTM -9.82%
Return on equity TTM -167.38%
Profit margin -44.65%
Book value $2.792
Market capitalisation USD$4.2 million

TTM: trailing 12 months

Shorting Endologix shares

There are currently 343,574 Endologix shares held short by investors – that's known as Endologix's "short interest". This figure is 45.3% up from 236,448 last month.

There are a few different ways that this level of interest in shorting Endologix shares can be evaluated.

Endologix's "short interest ratio" (SIR)

Endologix's "short interest ratio" (SIR) is the quantity of Endologix shares currently shorted divided by the average quantity of Endologix shares traded daily (recently around 377553.84615385). Endologix's SIR currently stands at 0.91. In other words for every 100,000 Endologix shares traded daily on the market, roughly 910 shares are currently held short.

However Endologix's short interest can also be evaluated against the total number of Endologix shares, or, against the total number of tradable Endologix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Endologix's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Endologix shares in existence, roughly 20 shares are currently held short) or 0.0202% of the tradable shares (for every 100,000 tradable Endologix shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Endologix.

Find out more about how you can short Endologix stock.

Endologix share dividends

We're not expecting Endologix to pay a dividend over the next 12 months.

Have Endologix's shares ever split?

Endologix's shares were split on a 1:10 basis on 6 March 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Endologix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Endologix shares which in turn could have impacted Endologix's share price.

Endologix share price volatility

Over the last 12 months, Endologix's shares have ranged in value from as little as $0.0199 up to $3.8. A popular way to gauge a stock's volatility is its "beta".

ELGX.US volatility(beta: 0.74)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Endologix's is 0.735. This would suggest that Endologix's shares are less volatile than average (for this exchange).

Endologix overview

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California. On July 5, 2020, Endologix, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas. It is in joint administration with TriVascular Sales LLC.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site